IN233529: An anti arrhythmic compound designated as kcv-caf obtained from the venom of indian snake king cobra ophiophagus hannah

The invention relates to an anti arrhythmic pharmaceutical comprising an effective amount of compound designated as KCV-CAF obtained from the venom of Indian snake King Cobra (Ophiophagus hannah) and optionally pharmaceutically acceptable ingredients and a process of isolating the said compound KCV-CAF from the venom of the Indian snake King Cobra (Ophiophagus hannah).